Advertisement
Del-Immune V(R), a dietary supplement, is the result of research beginningin the 1960's in Cold War-era Russia. Soviet researchers discovered that bybreaking open the cells of particular strains of lactobacillus bacteria, aprocess called "lysing," they could access immune support components fromwithin the cells. These components, including muramyl peptides, stimulatedproduction of interferons and tumor necrosis factor (TNF).
Advertisement
A Bulgarian researcher, Dr. Ivan Bogdanov, induced cancer in mice and theninjected the animals with a lactobacillus lysate in 1962. He reported thatthe cancer disappeared within a few days. In following months, Bogdanov andhis research team were unable to reintroduce cancer in the original micetreated with the lactobacillus lysate. The researchers also found the lysateformula had no side effects.
The American-made product is the contemporary adaptation of the Sovietresearch. It was introduced in the U.S. by a retired Colorado pharmacist whenhe observed the lactobacillus lysate's effect of eliminating his daughter'sHepatitis C symptoms. The product is now manufactured in the U.S. by VivolacLaboratories of Indianapolis, Ind.
This release was issued through eReleases(TM). For more information,visit http://www.ereleases.com.CONTACT: Pamela Sichel of Pure Research Products, LLC +1-303-530-7761 Web site: http://www.delimmune.com/
SOURCE Pure Research Products, LLC